MT3 and COVID-19: MT3 (iMon: GzmBHigh, HLA-DRHigh, TIM3High, LAG3High and PD1neg) also increased in COVID19 and NON-COV-RTI patients compared with HDs and this change was also significant in NON-COV-RTI versus COVID19.